Mahren B - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Radioimmunotherapy with anti-CD66 antibody: improving the biodistribution using a physiologically based pharmacokinetic model.

Kletting P, Kull T, Bunjes D, Mahren B, Luster M, Reske SN, Glatting G. Kletting P, et al. Among authors: mahren b. J Nucl Med. 2010 Mar;51(3):484-91. doi: 10.2967/jnumed.109.067546. Epub 2010 Feb 11. J Nucl Med. 2010. PMID: 20150257 Free article. Clinical Trial.

Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemia.

Neumaier B, Mottaghy FM, Buck AK, Glatting G, Blumstein NM, Mahren B, Vogg AT, Reske SN. Neumaier B, et al. Among authors: mahren b. Cancer Biother Radiopharm. 2008 Dec;23(6):819-24. doi: 10.1089/cbr.2008.0512. Cancer Biother Radiopharm. 2008. PMID: 19111052

Population-Based Modeling Improves Treatment Planning Before (90)Y-Labeled Anti-CD66 Antibody Radioimmunotherapy.

Maaß C, Kletting P, Bunjes D, Mahren B, Beer AJ, Glatting G. Maaß C, et al. Among authors: mahren b. Cancer Biother Radiopharm. 2015 Sep;30(7):285-90. doi: 10.1089/cbr.2015.1878. Epub 2015 Jul 14. Cancer Biother Radiopharm. 2015. PMID: 26172337

Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy.

Shen C, Rattat D, Buck A, Mehrke G, Polat B, Ribbert H, Schirrmeister H, Mahren B, Matuschek C, Reske SN. Shen C, et al. Among authors: mahren b. Cancer Biother Radiopharm. 2003 Feb;18(1):17-26. doi: 10.1089/108497803321269296. Cancer Biother Radiopharm. 2003. PMID: 12667305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters